Cargando…

Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease

Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Alexandru, Constantin, Alina, Alexandru, Nicoleta, Voicu, Geanina, Constantinescu, Cristina Ana, Rebleanu, Daniela, Fenyo, Madalina, Simionescu, Dan, Simionescu, Agneta, Manduteanu, Ileana, Georgescu, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563030/
https://www.ncbi.nlm.nih.gov/pubmed/32841051
http://dx.doi.org/10.1177/0963689720946277
_version_ 1783595399651524608
author Filippi, Alexandru
Constantin, Alina
Alexandru, Nicoleta
Voicu, Geanina
Constantinescu, Cristina Ana
Rebleanu, Daniela
Fenyo, Madalina
Simionescu, Dan
Simionescu, Agneta
Manduteanu, Ileana
Georgescu, Adriana
author_facet Filippi, Alexandru
Constantin, Alina
Alexandru, Nicoleta
Voicu, Geanina
Constantinescu, Cristina Ana
Rebleanu, Daniela
Fenyo, Madalina
Simionescu, Dan
Simionescu, Agneta
Manduteanu, Ileana
Georgescu, Adriana
author_sort Filippi, Alexandru
collection PubMed
description Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in the aortic valve in order to identify possible therapeutic targets in diabetes-associated cardiovascular disease. A streptozotocin-induced diabetic apolipoprotein E knock-out (ApoE(−/−)) mouse model was used to identify the early and progressive changes, at 4 or 7 days on atherogenic diet after the last streptozotocin or citrate buffer injection. Blood and aortic valves from diabetic or nondiabetic ApoE(−/−) animals were collected. EPCs were identified as CD34 and vascular endothelial growth factor receptor 2 positive monocytes, and the expression levels of α(4)β(1), α(V)β(3), α(V)β(5), β(1), α(L)β(2), α(5) integrins, and C-X-C chemokine receptor type 4 chemokine receptor on EPC surface were assessed by flow cytometry. The number of CD34 positive cells in the aortic valve, previously found to be recruited progenitor cells, was measured by fluorescence microscopy. Our results show that aortic valves from mice fed 7 days with atherogenic diet presented a significantly higher number of CD34 positive cells compared with mice fed only 4 days with the same diet, and diabetes reversed this finding. We also show a reduction of circulatory EPC numbers in diabetic mice caused by cell senescence and lower mobilization. Dyslipidemia induced EPC death through apoptosis regardless of the presence of diabetes, as shown by the higher percent of propidium iodide positive cells and higher cleaved caspase-3 levels. EPCs from diabetic mice expressed α4β1 and α(V)β(3) integrins at a lower level, while the rest of the integrins tested were unaffected by diabetes or diet. In conclusion, reduced EPC number and expression of α4β1 and αVβ3 integrins on EPCs at 4 and 7 days after diabetes induction in atherosclerosis-prone mice have resulted in lower recruitment of EPCs in the aortic valve.
format Online
Article
Text
id pubmed-7563030
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75630302020-10-26 Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease Filippi, Alexandru Constantin, Alina Alexandru, Nicoleta Voicu, Geanina Constantinescu, Cristina Ana Rebleanu, Daniela Fenyo, Madalina Simionescu, Dan Simionescu, Agneta Manduteanu, Ileana Georgescu, Adriana Cell Transplant Original Article Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in the aortic valve in order to identify possible therapeutic targets in diabetes-associated cardiovascular disease. A streptozotocin-induced diabetic apolipoprotein E knock-out (ApoE(−/−)) mouse model was used to identify the early and progressive changes, at 4 or 7 days on atherogenic diet after the last streptozotocin or citrate buffer injection. Blood and aortic valves from diabetic or nondiabetic ApoE(−/−) animals were collected. EPCs were identified as CD34 and vascular endothelial growth factor receptor 2 positive monocytes, and the expression levels of α(4)β(1), α(V)β(3), α(V)β(5), β(1), α(L)β(2), α(5) integrins, and C-X-C chemokine receptor type 4 chemokine receptor on EPC surface were assessed by flow cytometry. The number of CD34 positive cells in the aortic valve, previously found to be recruited progenitor cells, was measured by fluorescence microscopy. Our results show that aortic valves from mice fed 7 days with atherogenic diet presented a significantly higher number of CD34 positive cells compared with mice fed only 4 days with the same diet, and diabetes reversed this finding. We also show a reduction of circulatory EPC numbers in diabetic mice caused by cell senescence and lower mobilization. Dyslipidemia induced EPC death through apoptosis regardless of the presence of diabetes, as shown by the higher percent of propidium iodide positive cells and higher cleaved caspase-3 levels. EPCs from diabetic mice expressed α4β1 and α(V)β(3) integrins at a lower level, while the rest of the integrins tested were unaffected by diabetes or diet. In conclusion, reduced EPC number and expression of α4β1 and αVβ3 integrins on EPCs at 4 and 7 days after diabetes induction in atherosclerosis-prone mice have resulted in lower recruitment of EPCs in the aortic valve. SAGE Publications 2020-08-25 /pmc/articles/PMC7563030/ /pubmed/32841051 http://dx.doi.org/10.1177/0963689720946277 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Filippi, Alexandru
Constantin, Alina
Alexandru, Nicoleta
Voicu, Geanina
Constantinescu, Cristina Ana
Rebleanu, Daniela
Fenyo, Madalina
Simionescu, Dan
Simionescu, Agneta
Manduteanu, Ileana
Georgescu, Adriana
Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title_full Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title_fullStr Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title_full_unstemmed Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title_short Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
title_sort integrins α4β1 and αvβ3 are reduced in endothelial progenitor cells from diabetic dyslipidemic mice and may represent new targets for therapy in aortic valve disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563030/
https://www.ncbi.nlm.nih.gov/pubmed/32841051
http://dx.doi.org/10.1177/0963689720946277
work_keys_str_mv AT filippialexandru integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT constantinalina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT alexandrunicoleta integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT voicugeanina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT constantinescucristinaana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT rebleanudaniela integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT fenyomadalina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT simionescudan integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT simionescuagneta integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT manduteanuileana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease
AT georgescuadriana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease